[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Healthcare Deal Multiples (Select Transaction) - Part l

November 2013 | 62 pages | ID: HD741BAF0A7EN
Reevolv Advisory Services Private Limited

US$ 500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Executive summary

Reevolv Valuation and Deal Multiples Report helps in depth understanding of current valuations prevalent in the industry. The report is an extensive analysis of various rounds of funding the companies in Healthcare sector have secured through various Private Equity Transactions. The report projects actual Deal Multiples derived from the statutory filings made by the companies. The report does not refer to any news article as a source of information.

The report is beneficial for the companies from healthcare industry and various financial institutions to understand the trends in Healthcare industry in India from valuation perspective.

Key highlights
  • Player Profiles – Overview of the investee company, Geographic spread
  • Shareholding Pattern – Instrument, Break up of instrument, Percentage holding
  • Historical Financials – Profit & Loss Account, Balance Sheet, Key Ratios
  • Valuations – Investor, Instruments used, Amount Invested, Percentage stake acquired
  • Deal Multiples – EV/Sales, EV/EBITDA, P/E
  • Players covered – ASG Eye Hospital, Axiss Dental, Centre for Sight, DaVita NephroLife, Diwan Chand, Forus, International Oncology, NationWide Primary Healthcare, NephroPlus, Xcyton
  • Investors – Sequoia Capital, India Equity Partners, Matrix Partners, New Enterprise Associates, DaVita, Asian Healthcare Fund, IDG Ventures, Accel India, Rajasthan Ventures, Northwest Ventures Partners, Bessemer Venture Partners, Fidelity India Venture
1. PLAYERS PROFILE

1.1. ASG Eye Hospital
1.2. Axiss Dental
1.3. Centre for Sight
1.4. DaVita NephroLife
1.5. Diwan Chand
1.6. Forus
1.7. International Oncology
1.8. NationWide Primary Healthcare
1.9. NephroPlus
1.10. Xcyton

2. ANNEXURE


More Publications